Auteur S. P. ELLIOTT

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Analytical and pharmacological characterization of 1-(furan-2-carbonyl)-LSD (1F-LSD) and comparison with 1-(thiophene-2-carbonyl)-LSD (1T-LSD)

S. D. BRANDT ; P. V. KAVANAGH ; S. GARE ; S. P. ELLIOTT ; A. STRATFORD ; A. L. HALBERSTADT | 2025
Dans Drug Testing and Analysis (Vol.17, n°8, August 2025) Article : Périodique

The classical psychedelic drug (+)-lysergic acid diethylamide (LSD) continues to attract considerable multidisciplinary interest, and over the last eight decades, many derivatives and analogs of LSD have been synthesized. One site on the ergolin[...]

Plus d'info

Ajouter à la sélection

Lien externe

Multiple fatalities involving a new designer drug: para-methyl-4-methylaminorex

S. COSBEY ; S. KIRK ; M. McNAUL ; L. PETERS ; B. PRENTICE ; A. QUINN ; S. P. ELLIOTT ; S. D. BRANDT ; R. P. ARCHER | 2014
Dans Journal of Analytical Toxicology (Vol.38, n°6, July-August 2014) Article : Périodique

In recent years, the pace at which new psychoactive substances (NPS) have emerged has accelerated considerably. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported that between 2005 and 2011, 164 NPS were formally notif[...]

Plus d'info

Ajouter à la sélection

Prodrugs of new psychoactive substances (NPS): A new challenge

S. P. ELLIOTT ; T. HOLDBROOK ; S. D. BRANDT | 2020
Dans Journal of Forensic Sciences (Vol.65, n°3, May 2020) Article : Périodique

The concept of a substance acting as a prodrug for an intended drug is not new and has been known and utilized with particular benefits within medicine for efficacy and patient safety. Prodrugs of psychoactive substances are also not particularl[...]

Plus d'info

Ajouter à la sélection